Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that ...
Q2 2026
Aug 6, 2026
Q1 2026
May 8, 2026
FY 2025
Dec 31, 2025
Q1 2025
Mar 31, 2025
FY 2024
Dec 31, 2024